physician photo

Kathleen G. Raman, MD, MPH, FACS

  • Assistant Professor of Surgery

Medical School

M.D., Columbia University, College of Physicians and Surgeons, 1998.

Graduate School

M.P.H., Columbia University, Mailman School of Public Health. 1998.

Post Doctoral Education

Internship, General Surgery, University of Pittsburgh Medical Center, 1998-1999.

Residency, General Surgery, University of Pittsburgh Medical Center, 1999-2006.

Fellowship, Vascular Surgery, Washington University in St. Louis, 2006-2007.

Board Certifications

General Surgery--Certified
Vascular Surgery--Certified
Credentialed in Vascular Ultrasound (RPVI)

Clinical Interests

Dr. Raman specializes in all aspects of endovascular and open vascular surgery.

Her areas of clinical interest include treatment for carotid stenosis, abdominal and thoracic aneurysm and dissection, aortoiliac occlusive disease, surgery for dialysis access, peripheral arterial occlusive disease, and varicose veins. 

Specialty Areas:
Endovascular Treatment and Surgery
Carotid Disease
Cerebrovascular Disease
Dialysis Access Surgery
Aneurysms and Vascular Malformations
Venous Thromboembolism
Varicose Veins
Vascular Surgery

Research Interests

Pathobiology of abdominal aortic aneurysm (AAA).

Hospital Affiliations

Barnes-Jewish Hospital, St. Louis
Barnes-Jewish West County Hospital
John Cochran Veterans Administration Hospital, St. Louis
Marion Veterans Administration Hospital, St. Louis

Patients Seen At

Center for Advanced Medicine
Heart and Vascular Center
4921 Parkview Place, Suite A, Floor 8
St. Louis, MO 63110
(314) 362-6460
Fax: (314) 362-6216

Selected Publications

Raman KG, Gandley RE, Rohland JD, Zenati MS, Tzeng E. Early Hypercholesterolemia Contributes to the Vasomotor Dysfunction and Injury Associated Atherogenesis that can be Inhibited by Nitric Oxide. J Vasc Surg. (in press)

Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, Tzeng E, Ahmad S, Ahmed A, Baty CJ, Otterbein LE. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation. 2010 Feb 2;121(4):537-48.

Ramlawi B, Scott JR, Feng J, Mieno S, Raman KG, Gallo D, Csizmadia E, Chin BY, Bach FH, Otterbein LE, Sellke FW. Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg Res. 2007 Mar;138(1):121-7.

Raman KG, Sappington PL, Yang R, Levy RM, Prince JM, Liu S, Watkins SK, Schmidt AM, Billiar TR, Fink MP. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol. 2006;291(4):G556-G565.

Raman KG, Barbato JE, Ozanich BA, Ifedigbo E, Otterbein LE, Tzeng E. Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. Journal of Vascular Surgery. 2006;44(1):151-158.

Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in Type II diabetes mellitus. Am J Physiol Heart Circ Physiol. 2005;289(1):H228-H236.

Raman KG, Sappington PL, Yang R, Liu F, Otterbein LE, Schmidt AM, Fink MP, Billiar TR. Essential role of receptor for advanced glycation end products in the inflammatory response and mucosal injury following hemorrhagic shock. Journal of the American College of Surgeons. 2004;199(3S):S36-S37.

Raman KG, Shapiro RA, Tzeng E, Kibbe M. Adenovirus-mediated nitric oxide synthase gene transfer. Methods in Molecular Biology. 2004;279:225-234.

Raman KG, Layne S, Makaroun MS, Kelley ME, Rhee RY, Tzeng E, Muluk VS, Muluk SC. Disease progression in contralateral carotid artery is common after endarterectomy. Journal of Vascular Surgery. 2004;39(1):52-57.

Raman KG, Missig-Carroll N, Richardson T, Muluk SC, Makaroun MS. Color-flow duplex ultrasound scan versus computed tomographic scan in the surveillance of endovascular aneurysm repair. Journal of Vascular Surgery. 2003;38(4):645-651.

Raman KG, Tsai M, Ferran Jr. L, Fan L, Lindenberg N, Stern D, Berglund L, Huang LS, Schmidt AM. Genetically diabetic (db/db) transgenic mice overexpressing human apolipoprotein B (HuBTg) exhibit accelerated atherosclerosis. Circulation suppl. 1998;98:17 Abst. #2445, p. 465.

Park L*, Raman KG* (*co-authors), Lee KJ, Lu Y, Ferran Jr. L, Chow WS, Stern D, Schmidt AM. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nature Medicine. 1998;4(9).

Raman KG, Lu Y, Tsai M, Ferran Jr. L, Chow WS, Berglund L, Huang LS, Schmidt AM. A model of accelerated atherosclerosis in diabetic mice overexpressing human apo B: Suppression by soluble receptor for advanced glycation end products. The FASEB Journal. 1998. Abstracts Part 1, Abst. #618, p. A106.

Raman KG, Radhakrishnan J, Valeri A, Chen JM, Benvenisty AI, Hardy MA. Toxicity of anticardiolipin antibody in hemodialysis vascular access failure. Owen H. Wangensteen Surgical Forum Volume XLVIII, 1997.

Raman KG, McCrudden KW, Lu Y, Ginsberg MD, Ferran Jr. L, Stern D, Huang LS, Schmidt AM. Diabetes in male human apo B transgenic mice results in accelerated atherosclerosis with minimal modification of lipid profile. Arteriosclerosis. 1997. Vol. 2, Abst. #9411, P. 111.

Park L, Raman KG, Lee KJ, Lu Y, Ginsberg MD, Ferran Jr. L, Stern D, Schmidt AM. A murine model of accelerated atherosclerosis: suppression by soluble receptor for advanced glycation end products. Circulation suppl. 1997;96:8 Abst. #3079, p. 550.

Pub Med page for Kathleen G. Raman, M.D., MPH